Dr. Tianlu Wang 王天禄
Chief Physician
Department of Radiation Oncology, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy, chemotherapy, immunotherapy, and targeted therapy for thoracic, digestive, and head and neck cancers, including lung, esophageal, liver, gastric, pancreatic, rectal, nasopharyngeal, and hypopharyngeal cancers, as well as brain, lung, liver, and bone metastases.
Dr. Wang is Director of the Thoracic Radiation Therapy Department at Liaoning Cancer Hospital & Institute and a doctoral supervisor. With 30 years in oncology, Dr. Wang uses CyberKnife, TomoTherapy, and volumetric modulated arc therapy. The department describes its care for thoracic tumors and metastases as reaching an advanced domestic level.
Professional roles
- Chair, Tumor Radioimmunotherapy Branch, Liaoning Life Science Society
- Vice Chair, Radiation Oncology Branch, Liaoning Medical Association
- Vice Chair, Bone Metastasis Medical Expert Committee, Liaoning Red Cross Foundation
- Standing Committee Member, Radioimmunology Working Committee, China Cancer Radiation Therapy Alliance
Name order: in Chinese the family name comes first (Wang Tianlu). Papers usually list the name as Tianlu Wang or Wang T.
Selected publications
25 papers on PubMed matched by name and affiliation; 14 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2024 (senior author): Impact of lung adenocarcinoma subtypes on survival and timing of brain metastases. PubMed 39290244
- Front Oncol, 2024 (senior author): Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases. PubMed 38841157
- Clin Transl Immunology, 2024 (senior author): From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 2019. PubMed 38770238
- Front Oncol, 2024 (senior author): Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma. PubMed 38680859
- Mol Cancer, 2023 (senior author): Molecular mechanisms of tumor resistance to radiotherapy. PubMed 37322433
- J Pharm Anal, 2023 (senior author): Neutrophil elastase: From mechanisms to therapeutic potential. PubMed 37181292
- Front Oncol, 2022 (senior author): Thorax radiotherapy using (18)F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis. PubMed 36353556
- Stem Cell Res Ther, 2022 (senior author): How the mechanical microenvironment of stem cell growth affects their differentiation: a review. PubMed 35964140
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion